Peritoneal High Grade Serous Adenocarcinoma
1 clinical trials · Condition
◉ Watch Peritoneal High Grade Serous Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Lenvatinib for the Treatment of Serous Ovarian Cancer Patients (NCT05114421) | M.D. Anderson Cancer Center | 2021-11-09 |
Track Peritoneal High Grade Serous Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.